Acitretin and skin cancer in kidney transplanted patients. Clinical and histological evaluation and immunohistochemical analysis of lymphocytes, natural killer cells and Langerhans' cells in sun exposed and sun protected skin

Clinical Transplantation

Volumn 19, Issue 1, 2005, Pages 115-121

  Carneiro, Renata V ^a   Sotto, Mírian N ^a   Azevedo, Luiz Sergio ^a   Ianhez, Luiz E ^a   Rivitti, Evandro A ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Keratosis; Kidney transplant; Retinoids; Skin cancer

Indexed keywords

EMOLLIENT AGENT; ETRETIN; FRESH FROZEN PLASMA; SUNSCREEN; VITAMIN K GROUP;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ACTINIC KERATOSIS; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CANCER PREVENTION; CHEMOPROPHYLAXIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ECCHYMOSIS; EPISTAXIS; FEMALE; GINGIVA BLEEDING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LANGERHANS CELL; LIP DISEASE; LIVER INJURY; LOW DRUG DOSE; LYMPHOCYTE COUNT; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; SEPSIS; SKIN BIOPSY; SKIN CANCER; SKIN EXFOLIATION; SKIN PROTECTION; SUN EXPOSURE; T LYMPHOCYTE; URINARY TRACT INFECTION;

ACITRETIN; ADULT; AGED; FEMALE; HUMANS; KERATOLYTIC AGENTS; KERATOSIS; KIDNEY TRANSPLANTATION; KILLER CELLS, NATURAL; LANGERHANS CELLS; LYMPHOCYTES; MALE; MIDDLE AGED; SKIN NEOPLASMS; SUNLIGHT; ULTRAVIOLET RAYS;

EID: 13644256416     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2004.00311.x     Document Type: Article

References (33)

1. Penn I. De novo cancers in organ allograft recipients. Curr Opin Organ Transpl 1998: 3: 188.
2. Dréno B, Mansat E, Legoux B, Litoux P. Skin cancers in transplant patients. Nephrol Dial Transplant 1998: 13: 1374.
3. Odom R. Managing actinic keratosis with retinoids. J Amer Acad Dermatol 1998: 39: S74.
4. Berg D, Otley CC. Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management. J Am Acad Dermatol 2002: 47: 1; quiz 18-20.
5. Paula FJ, Ianhez LE. Tumores malignos no pós-transplante renal. J Bras Nefrol 1999: 21: 161.
6. Otley CC, Coldiron BM, Stasko T, Goldman GD. Decreased skin cancer after cessation of therapy with transplant-associated immunosupressants. Arch Dermatol 2001: 137: 459.
7. Streilein JW. Skin associated lymphoid tissue (SALT): origin and functions. J Invest Dermatol 1983: 80: 12.
8. Galvão M, Sotto MN, Kihara SM, Rivitti EA, Sabbaga E. Alterações na pele de pacientes portadores de insuficiência renal crônica em fase dialítica - um estudo morfológico e imuno-histoquímico. J Bras Nefrol 1996: 18: S32.
9. Galvão MM, Sotto MN, Kihara SM, Rivitti EA, Sabbaga E. Lymphocyte subsets and Langerhans' cells in sun protected and sun exposed skin of immunosuppressed renal allograft recipients. J Am Acad Dermatol 1998: 38: 38.
10. Murphy GF, Katz S, Kligman AM. Topical tretinoin replenishes CD1a positive epidermal Langerhans' cells in chronically photodamaged human skin. J Cutan Pathol 1998: 25: 30.
11. Gibson GE, O'Grady A, Kay EW, Leader M, Murphy GM. Langerhans' cells in benign, premalignant and malignant skin lesions of renal transplant recipients and the effect of retinoid therapy. J Eur Acad Dermatol Venereol 1998: 10: 130.
12. DiGiovanna JJ. Retinoid chemoprevention in patients at high risk for skin cancer. Med Pedriatr Oncol 2001: 36: 564.
13. Rook AH, Jaworsky C, Nguyten T, Grossman RA, Wolfe JT, Kligman AM. Beneficial effect of low dose systemic retinoid in combination with topical tretinoin for the treatment and prophylaxis of premalignant and malignant skin lesions in renal transplant recipients. Transplantation 1995: 59: 714.
14. Shuttleworth D, Marks R, Griffin PJA, Salaman JR. Treatment of cutaneous neoplasia with etretinate in renal transplant recipients. Q J Med 1988: 68: 717.
15. Hsu SM, Raine L, Fanger H. Use of avidin - biotin - peroxidase complex (ABC) in immunoperoxidase techniques. A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981: 29: 577.
16. Bieber T, Ring J, Braun-Falco O. Comparison of different methods for enumeration of Langerhans' cells in vertical cryossection of human skin. Br J Dermatol 1988: 118: 385.
17. Yuan ZF, Davis A, Macdonald K, Bailey RR. Use of acitretin for the skin complications in renal transplant recipients. N Z Med J 1995: 108: 255.
18. Bavinck JN, Tieben LM, Van der Woude FJ et al. Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study. J Clin Oncol 1995: 13: 1933.
19. McKenna DB, Murphy GM. Skin cancer chemoprophylaxis in renal transplant recipients: 5 years of experience using low-dose acitretin. Br J Dermatol 1999: 140: 656.
20. Berbis PH. Acitrétine. Ann Dermatol Venereol 2001: 128: 737.
21. Gilchrest BA. Treatment of photodamage with topical tretinoin: an overview. J Am Acad Dermatol 1997: 36(3 Pt 2): S27.
22. Bhawan J. Short and long term histologic effects of topical tretinoin on photodamaged skin. Int J Dermatol 1998: 37: 286.
23. Kang S, Voorhess JJ. Photoaging therapy with topical tretinoin: an evidenced-based analysis. J Am Acad Dermatol 1998: 39(2 Pt 3): S55.
24. Ducloux D, Carron PL, Rebibou JM et al. CD4 lymphocytopenia as a risk factor for skin cancers in renal transplant recipients. Transplantation 1998: 65: 1270.
25. Kerrow KJ, Mackie RM, Lesko MJ. The effect of oral retinoid therapy on the normal human immune system. Br J Dermatol 1988: 119: 313.
26. Medawar PB, Hunt R. Anti-cancer actions of retinoids. Immunology 1981: 42: 349.
27. Levine N. Role of retinoids in skin cancer treatment and prevention. J Am Acad Dermatol 1998: 39: S62.
28. Meunier L, Voorhees JJ, Cooper KD. In vivo retinoic acid modulates expression of class II major histocompability complex and function of antigen-presenting macrophages and keratonocytes in ultraviolet-exposed human skin. J Invest Dermatol 1996: 106: 1042.
29. Barnadas MA, Curell R, Moragas JM. Effects of topical tretionin on epidermal Langerhans' cells in photomaged skin. Int J Dermatol 1995: 34: 580.
30. Fernandez-Bussy RA, Schmitt D, Mauduit G, Thivolet J. Effects of aromatic retinoid (Ro 109359) on Langerhans' cells in lichen planus. Arch Dermatol Res 1983: 275: 105.
31. Tsambaos D, Orfanos CE. Ultrastuctural evidence suggesting an immunomodulatory activity of oral retinoid. Its effect on dermal components in psoriasis. Br J Dermatol 1981: 104: 37.
32. Reichrath J, Munssinger T, Kerber A et al. In situ detection of retinoid-X receptor expression in normal and psoriatic human skin. Br J Dermatol 1995: 133: 168.
33. Nakajima H, Kizaki M, Sonoda A, Mori S, Harigaya K, Ikeda Y. Retinoids (all-trans and 9-cis retinoic acid) stimulate production of macrophage colony-stimulating factor and granulocyte-macrophage colony-stimulating factor by human bone marrow stromal cells. Blood 1994: 84: 4107.